6.2. risk stratification clinical decision making. tumour stage difficult assess clinically utuc, useful stratify patients according low- high risk progression order identify likely benefit kidney-sparing treatment treated radical nephroureterectomy . factors consider risk stratification presented figure 6.1. level evidence consider individually size, multifocality hydronephrosis surrogate high-risk progression remains low. therefore, presence low-grade disease associated factors, shared decision-making process patient important discuss therapeutic strategy (kidney-sparing strategy rnu). pre-rnu models aiming predicting patient > pt2 /non-organ-confined disease published [190-194]. several risk stratification models assessed main aim identify better patients eligible kidney-sparing surgery [188,189,195-197]. prognostic nomograms based pre-operative factors post-operative pathological characteristics also available [169,192,198-203] may used counselling patients regarding follow-up administration peri-operative chemotherapy. nevertheless, despite moderate good discrimination accuracy, severe heterogeneity discourages use systematic ways. figure 6.1: risk stratification non-metastatic utuc according risk progression a> pt2 /non-organ-confined diseasect = computed tomography; urs = ureteroscopy; utuc = upper urinary tract urothelial carcinoma.* factors need present.**any factors need present.***in presence low-grade tumour factors strong predictors invasive disease.